CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Warner Chilcott Company LLC v. Zydus Pharmaceuticals (USA) Inc.

1:11-cv-01105

Overview

Case Number 1:11-cv-01105
Filing Date 2011-11-08
Status Terminated
Termination Date 2014-06-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Cadila Healthcare Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Plaintiff

Warner Chilcott Company LLC Operating Company

Represented By

4 Attorneys Listed

Counter Claimant

Zydus Pharmaceuticals (USA) Inc. Operating Company

Represented By

2 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6893662
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
Filed: 2001-11-15
Issued: 2005-05-17
Expired (Term Ended)
Expires: 2021-11-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

21

Dispositive

0

Granted

0

Denied

2

Pending / Review

19

Motions by Category

Claim Construction / Markman Filing 16 Motion to Strike / Sanctions 5

Key Dispositive Motions & Rulings

Motion to Strike / Sanctions Denied
ORDER Denying 155 MOTION to Strike Certain of Plaintiff's Expert Reports and Exclude Expert Evidence Relating to Secondary Considerations of Non-Obviousness, fi...
Entry #167 • 2013-10-24 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] REPLY BRIEF re 155 MOTION to Strike Certain Expert Reports and Exclude Expert Evidence Relating to Secondary Considerations of Non-Obviousness, filed b...
Entry #166 • 2013-10-21 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] ANSWERING BRIEF in Opposition re 155 MOTION to Strike Certain of Plaintiff's Expert Reports and Exclude Expert Evidence Relating to Secondary Considera...
Entry #161 • 2013-10-10 Document →
Motion to Strike / Sanctions Denied
MOTION to Strike Certain of Plaintiff's Expert Reports and Exclude Expert Evidence Relating to Secondary Considerations of Non-Obviousness - filed by Cadila Hea...
Entry #155 • 2013-09-23 Document →
Motion to Strike / Sanctions Pending / Under Review
[SEALED] OPENING BRIEF in Support re 155 MOTION to Strike Certain of Plaintiff's Expert Reports and Exclude Expert Evidence Relating to Secondary Considerations...
Entry #156 • 2013-09-23 Document →
Claim Construction / Markman Filing Pending / Under Review
Claim Construction ORDER (see Order for details). Signed by Judge Richard G. Andrews on 8/9/2013. (nms) (Entered: 08/09/2013)
Entry #149 • 2013-08-09 Document →

Docket Entries

(193 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Cadila Healthcare Limited, Zydus Pharmaceuticals (USA) Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-9722236.) - filed by Warner Chilcott Company LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(els) (Entered: 11/08/2011)

Entry #1 • 2011-11-08
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (els) (Entered: 11/08/2011)

Entry #2 • 2011-11-08
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/27/11. Date of Expiration of Patent: 11/15/21.Thirty Month Stay Deadline: 3/27/2014. (els) (Entered: 11/08/2011)

Entry #3 • 2011-11-08
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,893,662 B2;. (els) (Entered: 11/08/2011)

Entry #4 • 2011-11-08
1

Disclosure Statement pursuant to Rule 7.1 filed by Warner Chilcott Company LLC identifying Other Affiliate Warner Chilcott Holdings Company III Limited, Other Affiliate Warner Chilcott Holdings Company II Limited, Other Affiliate Warner Chilcott Limited, Other Affiliate WC Pharmaceuticals I Limited, Other Affiliate WC Luxco Sarl, Other Affiliate Warner Chilcott plc, Other Affiliate WC Luxembourg Sarl for Warner Chilcott Company LLC. (els) (Entered: 11/08/2011)

Entry #5 • 2011-11-08
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc